• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: Factors associated with successful discontinuation of immune suppression after allogenic hematopoietic cell transplantation

byAliya Ramjaun
October 7, 2019
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children

#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

1. Successful discontinuation of immune suppression after hematopoietic cell transplantation may be less likely in the setting of peripheral blood stem cell grafts, prior graft-versus-host disease, and earlier discontinuation efforts. 

Evidence Rating Level: 2 (Good)

Unlike after solid organ transplantation, immune suppression discontinuation is commonly attempted after hematopoietic cell transplantation (HCT). The basis of this strategy lies in the thought that immune tolerance develops and earlier immune suppression discontinuation supports graft vs. cancer effects and decreases the risk of opportunistic infections. To date, however, little data is available on the rate of successful immune suppression discontinuation in this context. In this cohort study, 827 patients that had undergone allogeneic HCT were followed up to examine factors associated with successful immune suppression discontinuation and risk for immune suppression discontinuation failure. A total of 342 patients, 41.4% of the total study population, were able to stop immune suppression. However, 127 of these patients (37.1%) resumed immune suppression for treatment of graft-versus-host disease (GVHD). Factors associated with a decreased odds of immune suppression discontinuation included older receipt age (OR 0.27, 99% CI 0.14 to 0.50 for age >50 years vs. <30 years), mismatched unrelated donor (OR 0.37, 99% CI 0.14 to 0.97, p=0.008), peripheral blood graft vs. bone marrow graft (OR 0.46, 99% CI 0.26 to 0.82, p<0.001), and advanced stage of disease (OR 0.45, 99% CI 0.23 to 0.86, p=0.002). Failed attempts at immune suppression discontinuation resulting in GVHD was found to be associated with the use of peripheral blood stem cells (HR 2.62, 99% CI 1.30 to 5.29, p<0.001), prior GVHD, and earlier immune suppression discontinuation attempts. Of note, earlier discontinuation was not associated with decreased cancer relapse after transplantation (HR 1.95, 99% CI 0.88 to 4.31). This study therefore shows that successful discontinuation of immune suppression may be less likely in the setting of peripheral blood stem cell grafts, and that earlier attempts at discontinuation may not confer any long-term benefit with respect cancer relapse. This study has important implications in the identification of patients likely to succeed or not in discontinuation of immune suppression.

Click to read the study in JAMA Oncology

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: graft versus hosthematopoietic cell transplantationimmune suppression
Previous Post

Quick Take: Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome

Next Post

#VisualAbstract: Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia

RelatedReports

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children
StudyGraphics

#VisualAbstract: Individualized dosing of anti-thymocyte globulin may improves outcomes of allogeneic haematopoietic stem-cell transplantation in children

February 17, 2022
#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft
StudyGraphics

#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft

October 28, 2021
#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients
StudyGraphics

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

June 25, 2021
#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)
The 2MM Team

#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)

December 25, 2020
Next Post
#VisualAbstract: Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia

#VisualAbstract: Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia

Downward trend in mortality rate for antineutrophil cytoplasmic autoantibody-associated vasculitis

Downward trend in mortality rate for antineutrophil cytoplasmic autoantibody-associated vasculitis

2 Minute Medicine Rewind October 7, 2019

2 Minute Medicine Rewind October 7, 2019

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Guidelines from many countries recommend physical activity during uncomplicated pregnancy
  • #VisualAbstract: Catheter ablation reduces rates of persistent atrial fibrillation and atrial tachyarrhythmia
  • Factors associated with breastfeeding rates in Canada
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options